Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 19, 2009

29777_dirs_2009-02-19_41109416-76b2-4edc-8dd6-077659866265.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-17

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-17 Common shares without par value F 2808 $54.94 Disposed 315029 Direct
2009-02-17 Common shares without par value S 100 $54.41 Disposed 314929 Direct
2009-02-17 Common shares without par value S 100 $54.4121 Disposed 314829 Direct
2009-02-17 Common shares without par value S 100 $54.4122 Disposed 314729 Direct
2009-02-17 Common shares without par value S 100 $54.4123 Disposed 314629 Direct
2009-02-17 Common shares without par value S 100 $54.4128 Disposed 314529 Direct
2009-02-17 Common shares without par value S 200 $54.414 Disposed 314329 Direct
2009-02-17 Common shares without par value S 254 $54.412 Disposed 314075 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 20962 Indirect
Common shares without par value 1567 Indirect
Common shares without par value 1567 Indirect
Common shares without par value 1567 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 13, 2009.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.